SCHEMBL6174658

SCHEMBL6174658

CCOC(=O)c1cnccc1C(C)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.34
MAPT P10636 3/20 0.34
IGF1R P08069 1/20 0.33
NR1H2 P55055 4/20 0.33
NR1H3 Q13133 3/20 0.33
LMNA P02545 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MAPK1 P28482 1/20 0.31
CA12 O43570 3/20 0.31
ALDH1A1 P00352 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA6 P23280 1/20 0.31
CA7 P43166 1/20 0.31
CA13 Q8N1Q1 1/20 0.31
POLB P06746 1/20 0.31
CA9 Q16790 2/20 0.31
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174458 0.87 SLC5A1 (0.40) MAPTLMNAL3MBTL1ALDH1A1POLB
SCHEMBL6172002 0.87 LMNA (0.41) RXFP1MAPTIGF1RLMNAALDH1A1
SCHEMBL6174640 0.85 IGF1R (0.37) RXFP1IGF1RLMNASMN1; SMN2MAPK1
SCHEMBL6175175 0.85 IGF1R (0.36) IGF1RLMNASMN1; SMN2MAPK1
SCHEMBL6170251 0.84 IGF1R (0.33) IGF1RLMNA
SCHEMBL6175260 0.84 IGF1R (0.39) IGF1RLMNASMN1; SMN2MAPK1
SCHEMBL6173330 0.83 IGF1R (0.40) IGF1RNR1H2NR1H3LMNASMN1; SMN2
SCHEMBL6171408 0.81 IGF1R (0.35) IGF1RLMNASMN1; SMN2MAPK1
SCHEMBL6175558 0.80 RXFP1 (0.35) RXFP1MAPTLMNASMN1; SMN2L3MBTL1
SCHEMBL6172647 0.80 CYP3A4 (0.35) RXFP1MAPTIGF1RNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed